1-(2-Methoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 95.0%, 1g

2,4-Decadien-1-ol>95.0%(GC)5mL

3-Bromo-5-(tert-butyl)-4-hydroxybenzaldehyde, 95%, 500mg

4-Hexyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiophene-2-carbaldehyde, 98%, 100mg

Pipettenspitzen 0,5–20 μl, Nachfülleinheit (palettiert), unsteril, 960 Stück

3-(propan-2-yl)pyridin-2-amine, 100mg

N-(Prop-2-yn-1-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide, 98%, 1g

4-(4-Ethylpiperazin-1-yl)phenylboronic acid pinacol ester, 95.0%, 10g

2-Bromoisophthalaldehyde>98.0%(GC)1g

2,4,6-trimethylquinoline, 95.0%, 1g

1-(3-(Trifluoromethyl)pyridin-2-yl)cyclopropane-1-carbonitrile, 98%, 5g

METHYL 6-FLUORO-5-METHYLPYRIDINE-3-CARBOXYLATE, 95.0%, 5g

2,6-Diaminoheptanedioic acid, 95.0%, 10g